Ala-Rämi Antti, Ylitalo Kari V, Hassinen Ilmo E
Department of Medical Biochemistry and Molecular Biology, University of Oulu, P.O. Box 5000, 90014 Oulu, Finland.
Basic Res Cardiol. 2003 Jul;98(4):250-8. doi: 10.1007/s00395-003-0413-z.
Ischaemic preconditioning gives powerful protection against prolonged ischaemia affecting several intracellular regulatory and messenger pathways, although their mutual importance is far from established. Protective, preconditioning-like effects have been reported for K(ATP) channel openers, and most of the evidence points to the mitochondrial K(ATP) channels. We show here that the K(ATP) channel opener diazoxide, which acts selectively on the mitochondrial channel, causes potentiation of ischaemic inhibition of mitochondrial ATP synthase (F(1)F(0)-ATPase) along with cardioprotection. These effects are comparable with that of ischaemic preconditioning. The administration of diazoxide did not affect the cellular energy state as monitored with (31)P NMR. The actions of both diazoxide and ischaemic preconditioning were prevented by 5-hydroxydecanoate, a specific inhibitor of the mitochondrial K(ATP) channel. Thus mitochondrial K(ATP) channel opening and ischaemic preconditioning must share common mechanisms of action involving mitochondrial F(1)F(0)-ATPase, although involvement of the energy state in protection could not be proved.
缺血预处理能对长时间缺血提供强大保护,涉及多种细胞内调节和信使通路,尽管它们之间的相互重要性尚未完全明确。已有报道称钾离子通道开放剂具有类似预处理的保护作用,且大部分证据指向线粒体钾离子通道。我们在此表明,选择性作用于线粒体通道的钾离子通道开放剂二氮嗪,会增强缺血对线粒体ATP合酶(F₁F₀ - ATP酶)的抑制作用,并伴有心脏保护作用。这些作用与缺血预处理的作用相当。用³¹P NMR监测发现,二氮嗪的给药并未影响细胞能量状态。线粒体钾离子通道的特异性抑制剂5 - 羟基癸酸可阻止二氮嗪和缺血预处理的作用。因此,线粒体钾离子通道开放和缺血预处理必定具有涉及线粒体F₁F₀ - ATP酶的共同作用机制,尽管能量状态在保护作用中的参与尚未得到证实。